Orexigen Therapeutics, Inc.’s (OREX) stock price is Worth at $4.10 while closes Friday with surge of 15.82%: Latest Updates

OREX Stock Price Comparison to Moving Averages:

USA based company, Orexigen Therapeutics, Inc.’s (OREX)’s latest closing price distance was at 19.64% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 62.36% and 22.15% compared with the 20 Day Moving Average.

Analysts Mean Rating:

Analysts’ mean recommendation for Orexigen Therapeutics, Inc.’s (OREX) stands at 3.30. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.

Performance Review:

To review the OREX previous performance, look at its past history, which highlighted below:

During last 5 trades the stock sticks almost 22.75%.

During last one month it showed the change of 20.59%.

During last 3 month it remained at 70.12%.

Along with these its year to date performance is standing at 135.63%.

Important Technical Indicators:

ATR value of company was 0.37. Relative Strength Index (RSI) was 73.05. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings and centerline crossovers. RSI can also be used to identify the general trend.

The stock volatility for week was 10.24% while for month was 12.24%.The stock, as of last close, traded 148.48% to its 52 week low and was changed -78.76% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as 2.86. OREX’s value Change from Open was at 14.53% with a Gap of 1.13%.

Earnings per share Details about OREX:

EPS growth in past 5 year was 13.70% along with sales growth of 81.80% in the last five years.

EPS growth in next year is estimated to reach 46.80% while EPS growth estimate for this year is set at -65.10%.


Orexigen Therapeutics, Inc.’s (OREX)’s Stock Price Trading Update:

Orexigen Therapeutics, Inc.’s (OREX), a part of Healthcare sector and belongs to Drug Manufacturers - Other industry; ended its day with a gain of 15.82% and finalized at the price of $4.10. During its last trading session, Stock traded with the total exchanged volume of 2.66 million shares. The average volume stands around 0.62 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 4.31. Relative volume is ratio between current volume and 3-month average value, intraday adjusted.



Leave a Reply

Your email address will not be published. Required fields are marked *